Teknova to Report First Quarter 2024 Financial Results on May 13, 2024
April 29, 2024 16:01 ET
|
Alpha Teknova, Inc.
HOLLISTER, Calif., April 29, 2024 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of...
Teknova Reports Fourth Quarter and Full Year 2023 Financial Results
March 11, 2024 16:01 ET
|
Alpha Teknova, Inc.
Full year 2023 total revenue was $36.7 million, down 11% year-over-yearAchieved 36% annual growth in the number of Clinical Solutions customers in 2023Company provides 2024 revenue guidance of $35-38...
Teknova to Report Fourth Quarter and Full Year 2023 Financial Results on March 11, 2024
February 21, 2024 16:01 ET
|
Alpha Teknova, Inc.
Teknova announces plans to issue fourth quarter and full year 2023 earnings report on March 11, 2024.
Teknova Reports Third Quarter 2023 Financial Results
November 09, 2023 16:01 ET
|
Alpha Teknova, Inc.
Teknova today announced financial results for the third quarter ended September 30, 2023.
Teknova to Report Third Quarter 2023 Financial Results on November 9, 2023
October 26, 2023 08:00 ET
|
Alpha Teknova, Inc.
Teknova today announced that the Company will report its financial results for the third quarter on Thursday, November 9, 2023, following close of market.
Teknova Launches Latest Proprietary AAV-Tek™ Product and End-to-End Plasmid Workflow Solutions to Streamline Therapeutic Process Development
September 27, 2023 08:00 ET
|
Alpha Teknova, Inc.
HOLLISTER, Calif., Sept. 27, 2023 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the research, discovery, development, and...
Teknova Announces Closing of $22.9 Million Concurrent Registered Direct Offering and Private Placement and Amends Credit Facility
September 19, 2023 16:01 ET
|
Alpha Teknova, Inc.
HOLLISTER, Calif., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the research, development, and commercialization of...
Teknova Announces Up to $22.9 Million Concurrent Registered Direct Offering and Private Placement
September 18, 2023 08:00 ET
|
Alpha Teknova, Inc.
HOLLISTER, Calif., Sept. 18, 2023 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the research, development, and commercialization of...
Teknova Announces New Board Member, Martha J. Demski
August 16, 2023 08:00 ET
|
Alpha Teknova, Inc.
HOLLISTER, Calif., Aug. 16, 2023 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the research, development, and commercialization of...
Teknova Reports Second Quarter 2023 Financial Results
August 10, 2023 16:01 ET
|
Alpha Teknova, Inc.
Second quarter 2023 total revenue was $11.5 million, up 26% sequentiallyReceived certification of new state-of-the-art facility for production of GMP-grade productsCompany revises 2023 revenue...